Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Acute lymphoblastic leukemia (ALL) Clinical Trials

Protocol Number Title
2009NTLS130
HM2018-16R :Hematologic Disorder Tissue Bank
2014CG123
MT2016-21 : COG AALL1331 - Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) "AALL1331 - Amgen, Inc."
2015NTIS003
MT2015-16R:Novartis CCTL019A2205B; MT2015-16R: Long Term Follow-Up of Patients Exposed to Lentiviral- Based CD19 directed CART Cell Therapy
2016CG108
AALL1521/INCB 18424-269 - A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK PathwayMutant Acute Lymphoblastic Leukemia
2017LS118
MT2017-45 :Chimeric Antigen Receptor ( CAR)-T Cell Therapy for Patients with Hematologic Malignancies
2017NTLS132
MT2017-37R Ultrasound Point Shear Wave Elastography (PSWE) for Diagnosis of Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS)

6 trials displayed